These data indicate that TLR3 expression on immune cells in the lung can be detrimental, and that TLR3-positive tumor macrophages might reveal an immunosuppressive context that contribute to sustain the progression of early stage NSCLC. This evidence concerns the gene TLR3 and non-small cell lung carcinoma.